UPLIFT · UPright radiotherapy: Learning, Innovation, Fellowship and Training
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2024-10-01 → 2028-09-30
- EU contribution
- €3,928,529
- Participants
- 23
- Scheme
- HORIZON-TMA-MSCA-DN
Lines connect the coordinator with its partners.
Project objective
Radiotherapy (RT) is a mainstay of modern cancer treatment. Conventionally, RT is delivered to the patient lying on a treatment couch, while a beam steering device (gantry) aims the radiation from any angle around the target. Positioning the patients in upright body posture (upRT) instead enables to orient the patient arbitrarily toward a fixed beam. This enables smaller facility footprint and reduced treatment cost, placing upRT in the core of the UN sustainable development goals, and opening global access to advanced treatment options: 80% of cancer patients live in countries which host only 5% of the worlds RT resources. Moreover, upRT improves patient comfort and is associated with anatomical and physiological advantages, such as reduced breathing motion. It therefore comes as no surprise that, with new upright patient positioning & imaging solutions entering the market, upRT is enjoying a surge in interest. Yet, key scientific questions remain, international guidelines for upRT are lacking, and existing RT workflows are geared to lying patients. As the first clinics adopt new upRT technologies, there is a global need for trained professionals in industry, clinics and academia, to reach the promised benefits for patient care. UPLIFT builds this next generation of experts by addressing key research questions related to: treatment planning, clinical workflow and equipment design. Leveraging latest upRT technology available through our world-class consortium, UPLIFT propels Europe to the forefront of the upRT paradigm shift. UPLIFT focuses on: Learning (through its academic and clinical centres of excellence); Innovation (through its leading industrial partners); Fellowship & Training (through an outstanding cross-sector programme of workshops, secondments & mentoring). Input from patient advocacy groups and an internationally renowned advisory board will maximise its impact. UPLIFT will revolutionize modern RT, making it more human, accessible and sustainable.
Original text from CORDIS.
Participants
- GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH · DarmstadtCoordinatorGermany
- ASG SUPERCONDUCTORS SPA · GenovaItaly
- CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD · LyonFrance
- CESKE VYSOKE UCENI TECHNICKE V PRAZE · PRAHACzechia
- COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD · LjubljanaSlovenia
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG · HeidelbergGermany
- EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY · Bruxelles / BrusselBelgium
- FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICA · PAVIA PVItaly
- HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF EV · DresdenGermany
- KUNGLIGA TEKNISKA HOEGSKOLAN · StockholmSweden
- LOUGHBOROUGH UNIVERSITY · LoughboroughUnited Kingdom
- Leo Cancer Care Ltd · SmallfieldUnited Kingdom
- PAUL SCHERRER INSTITUT · VILLIGEN PSISwitzerland
- RAYSEARCH LABORATORIES AB (PUBL) · STOCKHOLMSweden
- RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG · HeidelbergGermany
- SHEFFIELD HALLAM UNIVERSITY · SheffieldUnited Kingdom
- TECHNISCHE UNIVERSITAET DRESDEN · DresdenGermany
- TECHNISCHE UNIVERSITAT DARMSTADT · DarmstadtGermany
- THERAPANACEA · ParisFrance
- UNIVERSITA DEGLI STUDI DI GENOVA · GENOVAItaly
- UNIVERSITE PARIS-SACLAY · Gif-Sur-YvetteFrance
- UNIVERZA V LJUBLJANI · LjubljanaSlovenia
- UNIWERSYTET JAGIELLONSKI · KrakowPoland
Links
Data: CORDIS, © European Union